TRENDING :  Market Movers  |  Top 50   SPY (0.37%)    BA (-1.78%)    WTRH (-0.37%)    VXXB (0.25%)    UNIT (-0.32%)    UAA (0.64%)    TVIX (0.08%)    TJX (1.13%)    ASHS (2.11%)    AKTX (12.01%)    ADBE (0.27%)    ACHV (5.32%)    AAT (-0.05%)    SIRI (-1.79%)    SBGI (-2.07%)    ROKU (1.31%)    MMYT (-1.63%)    LRN (-1.49%)    KSU (1.37%)    JMU (4.35%)    JBLU (-0.66%)    GLBS (-17.98%)    DIS (-1.61%)    CDNA (0.74%)    BRS (0%)

 DPLO - Diplomat Pharmacy

$5.80 [0.25][4.51%]

Next Earnings



Trade Idea »


Quarterly Rating Chart


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $8.00
Low $7.00
Average $7.50
Current $5.80

CompanyAnalyst NamePT ActionActionRatingTargetDate
JP MorganLowersMaintainsHold$7.0012:00 AM
Morgan StanleyLowersMaintainsHold$8.0012:00 AM
*Last 90 days


Service NameTrader NamePosition TypeTarget %Target PriceTarget Date Issue Date
RenHen InvestmentsRenHen InvestmentsSubscribe326.62 %Subscribe02/25/2002/25/19View

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



No recommendations found.


Diplomat Pharmacy Inc (DPLO) Q4 2018 Earnings Conference Call Transcript

Image source The Motley Fool Diplomat Pharmacy Inc NYSE DPLO Q4 2018 Earnings Conference Call March 15 2019 8 00 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator

Here's Why Diplomat Pharmacy Stock Fell 13.6% Today

What happened Shares of Diplomat Pharmacy NYSE DPLO took a beating last month when the specialty pharmacy said it had to delay the release of its fourth quarter earnings results It needed extra time to figure out a noncash impairment charge related to the acquisition of

Earnings Reaction History: DIPLOMAT PHARMA, 88.9% Follow-Through Indicator, 14.3% Sensitive

Expected Earnings Release 02 25 2019 After hoursExpected Earnings Release 02 25 2019 After hours Avg Extended Hours Dollar Volume 2 292 795Avg Extended Hours Dollar Volume 2 292 795 DIPLOMAT PHARMA DPLO is due to issue its quarterly earnings report in the upcoming extended

Why, Campbell Soup, and Diplomat Pharmacy Slumped Today

Friday was a good day on Wall Street as investors celebrated the prospects for a possible end to the U S trade war with China The Dow Jones Industrial Average crossed the 26 000 mark finishing with triple digit gains and leading other major benchmarks higher as well However

Here's Why Diplomat Pharmacy Is Tanking Again Today

What happened Shares of Diplomat Pharmacy NYSE DPLO 160 a specialty pharmaceutical company are getting hammered after the company told investors it would have to reschedule its annual earnings report conference call until March 15 2018 due to customer losses from

Friday Sector Laggards: Food, Diagnostics

In trading on Friday food shares were relative laggards down on the day by about 2 5 Helping drag down the group were shares of The Kraft Heinz Company KHC off about 28 1 and shares of Campbell Soup Company CPB off about 8 8 on the day Also lagging the market Friday

First Week of DPLO April 18th Options Trading

Investors in Diplomat Pharmacy Inc Symbol DPLO saw new options begin trading this week for the April 18th expiration At Stock Options Channel our YieldBoost formula has looked up and down the DPLO options chain for the new April 18th contracts and identified one put and one call contract

Diplomat Pharmaceuticals (DPLO) Reports Next Week: Wall Street Expects Earnings Growth

Diplomat Pharmaceuticals DPLO is expected to deliver a year over year increase in earnings on higher revenues when i t report s results for the quarter ended December 2018 This widely known consensus outlook gives a good sense of the company s earnings picture but how the actual